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Abstract  Article Information 
Development of the meclizine hydrochloride solid dispersions using polyethylene glycol 
8000 is not only to enhance the solubility and dissolution rate but also to produce rapid 
onset of action. The objectives of present research are to improve the solubility and 
dissolution rate of meclizine hydrochloride using solid dispersion method. In the present 
study, the solid dispersions were prepared using solvent evaporation method and 
evaluated for different physical parameters such as solubility, drug carrier compatibility and 
powder flow properties. From the results of solubility studies, F4 formulation was selected 
to prepare the fast dissolving tablets because it showed highest improvement in the 
solubility among the all formulations and compared with control tablets (conventional 
tablets using pure drug). The percent drug release in 15 min (Q15) and initial dissolution 
rate for F4 tablets was 98.52±1.34%, 6.56%/min and these were very much higher 
compared to control tablets (32.49±1.29 %, 2.17%/min). The relative dissolution rate was 
found to be 3.03 and dissolution efficiency was found to be 54.45 and it is increased by 3.5 
fold with F4 formulation compared to control tablets (16.55). Hence the formulation of 
polyethylene glycol 8000 solid dispersions is a suitable method to enhance the solubility 
and dissolution rate of meclizine hydrochloride. Further research warranted to study the 
efficacy of the developed formulations has to be assessed by pharmacokinetic studies.  
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INTRODUCTION 
Now days, the pharmaceutical formulation scientists 
are extensively paying the attention on development of 
oral dosage forms of poor aqueous solubility drugs 
through various solubility enhancing approaches (Kaushik 
et al., 2004). Among those, solid dispersions is one of the 
widely used approaches to of enhance the solubility and 
dissolution rate of poorly water-soluble drugs (Patil and 
Gaikwad, 2009). Solid dispersions are defined as 
molecular dispersions of drugs in a polymer in solid form. 
Solvent evaporation method and fusion method are widely 
used to formulate the solid dispersions (Vippagunta et al., 
2002).  
 
Meclizine hydrochloride (MCZ) is a first-generation 
antihistamine of the piperazine class drug. It is acting as 
H1 receptor antagonist and practically insoluble in water 
(Goyani et al., 2012). MCZ is widely used in the treatment 
of motion sickness, but due to poor water solubility 
delayed the onset of action. To overcome this problem, 
this drug is selected for the present study. Nimisha et al. 
(2012) formulated the MCZ mouth dissolving tablets to 
enhance the dissolution rate as well as the patient 
compliance. In this study, mouth dissolving tablets were 
prepared by superdisintegrant addition and sublimation 
technique and they showed sufficient mechanical integrity 
to assist patients of any age group for easy 
administration. George and Vasudevan (2012) were 
prepared the cyclodextrin-MCZ inclusion complexes to 
investigate the effect of 2-hydroxypropyl-β-cyclodextrins 
and β-cyclodextrins on MCZ aqueous solubility and 
dissolution. The phase solubility profile indicated that the 
solubility of MCZ was significantly increased in the 
presence of both 2-hydroxypropyl-β-cyclodextrin and β- 
cyclodextrin and their in vitro dissolution study were 
showed that, the solubility and dissolution rate of MCZ 
were significantly improved by complexation with 2-
hydroxypropyl-β-cyclodextrin. Vangala et al. (2014) 
developed and prepared the MCZ sublimated fast 
dissolving tablets to improve the dissolution rate and the 
tablets containing 10% w/w camphor as sublimating agent 
showed rapid drug release when compared to other 
formulations. Gupta et al. (2011) developed the MCZ 
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rapidly dissolving oral films to enhance the dissolution rate 
and to mask the bitter taste. In this study, the fast 
dissolving films with suitable appearance, mechanical 
strength and disintegration time were obtained using 
Methocel E-5 as a primary film former. MCZ, a poorly 
water soluble and bitter drug could be successfully 
incorporated in the fast dissolving films with the help of 
solubilizers such as β-Cyclodextrine and polyethylene 
glycol 400. The perusal of the literature showed that there 
is no literature available on the use of less polymer 
concentration for the preparation of fast dissolving tablets. 
Hence, the present research has been undertaken to 
formulate the MCZ fast dissolving tablets of using solid 
dispersion method to enhance the solubility and 
dissolution rate.  
 
MATERIALS AND METHODS 
Materials 
Meclizine hydrochloride was gift sample from Symed 
labs Ltd, India. Polyethylene Glycol 8000 and all other 
reagents used were of analytical grade and obtained from 
S.D. Fine Chemicals, Mumbai, India.    
 
Preparation of Solid Dispersions  
In this study, MCZ solid dispersions were prepared by 
the solvent evaporation method using PEG 8000 as 
carrier (Table 1). Accurately weighed amount of drug and 
carriers in various ratios dissolved in ethanol in a round 
bottom flask and the solvent was evaporated at 40°C 
temperature. Then it was stored in a vacuum oven at 
room temperature for 48 h to remove the residual solvent. 
The dried solid dispersions were grinded, passed through 
sieve # 60 and stored in desiccators until use (Chaitanya 
et al., 2014).  
 







F1 25 1:0.5 
F2 25 1:1 
F3 25 1:2 
F4 25 1:4 
F5 25 1:6 
F6 25 1:8 
 
Solubility Studies 
The prepared solid dispersions were evaluated for 
solubility studies in 0.1 N HCl, distilled water and 7.4 pH 
phosphate buffers. An excess amount of MCZ solid 
dispersion was weighed and transferred into conical flasks 
which contain 10 ml of media. The content in conical flask 
were sonicated for 2 h at room temperature, there after  
the samples were placed on a shaker, agitated at room 
temperature for 48 h. Subsequently, the suspensions 
were filtered through a Whatman filter paper. The filtrate 
was suitably diluted and analyzed spectrophotometrically 
at a wavelength of 232 nm using a double beam UV-
Visible spectrophotometer (Vaskula et al., 2012).  
 
Drug-carrier Interaction Studies 
The thermograms were recorded for drug, carrier, and 
physical mixture using differential scanning calorimeter 
(Shimadzu, Japan). About 2-4 mg sample in an open 
aluminium standard pan was heated at a scanning rate of 
5
0 
C/min from a temperature 0 to 450 
0
C under a nitrogen 
gas flow (Neduri et al., 2013).  
 
Evaluation of Flow Properties 
The flow properties were determined by calculating the 
angle of repose and Carr’s index. Powder mixtures of 
different formulations were evaluated for angle of repose, 
bulk density, tapped density and Carr’s index. The fixed 
funnel method was employed to measure the angle of 
repose (θ) and it was calculated using the following 
formula: 
 
           Tan θ = h/r ………………………….[1] 
 
In which, θ is the angle of repose, h is the height of the 
cone and r is radius of the cone base. To measure the 
angle of repose, a funnel was fixed to a stand so that the 
lower tip of funnel was 2.5 cm above the surface. A graph 
paper was placed on a flat surface. The powder blend 
was allowed to fall freely on the graph paper through the 
funnel (6.8 cm diameter), till the tip (8 mm diameter) of 
heap formed just touches the funnel. The radius of heap 
was noted and from this angle of repose was determined. 
The bulk density (ρb) of a powder is determined by 
measuring the volume of a known mass of powder sample 
that may have been passed through a screen, into a 50 ml 
graduated cylinder. Tapped density (ρtap) of powder 
samples were determined by a tap density apparatus. The 
apparatus was set for 500 tapings for 5 min at stroke 
height 20 mm at the rate of 100 strokes/min (Veerareddy 
and Vemula, 2012). The Carr’s Index is a measure of the 
propensity of a powder to be compressed and it is 
calculated using the following formula: 
 
Carr’s Index = [(ρtap - ρb) / ρtap] / ×100…………….[2] 
 
Preparation of Fast Dissolving Tablets 
Formulation F4 was selected to prepare the MCZ fast 
dissolving tablets (FDTs) based on the results of 
dissolution and solubility studies (Table 2). The FDTs 
were prepared by direct compression method. The solid 
dispersion powder equivalent to 25 mg of MCZ, 
crosspovidone and other excipients were passed through 
a mesh no 60. The powdered solid dispersion was mixed 
with proper portion of crosspovidone. Then excipients 
other than glidant and lubricant were added and mixed in 
a poly bag for 5-10 min. The obtained blend was 
lubricated with talc and magnesium stearate for another 5 
min and the resultant mixture was directly compressed 
into tablets using rotary tabletting machine (Vemula et al., 
2010).  
 




Ingredients in mg 
F4 Control 
MCZ Solid dispersion equivalent  
to 50 mg MCZ 
125 - 
Pure MCZ - 25 
Crosspovidone  10 10 
Spry-dried lactose 59 159 
Magnesium stearate  2 2 
Talc  4 4 
Total Tablet weight 200 200 
 
Evaluation of Physical Parameters 
The prepared tablets were studied for their physical 
properties like weight variation, hardness, friability and 
drug content unifrmity. For estimating weight variation, 20 
tablets of each formulation were weighed using an 
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electronic weighing balance (AW 120, Shimadzu 
Corporation, Japan). The hardness of six tablets was 
measured using Monsanto tablet hardness tester. 
Friability was determined on ten tablets in a Roche 
friabilator (Electrolab, Mumbai, India).  For estimation of 
drug content, ten tablets were crushed, and 100 mg of the 
powder was accurately weighed and transferred to a 100 
ml volumetric flask. Initially about 50 ml of 7.4 pH 
phosphate buffer was added to the volumetric flask and 
allowed to stand for 6-8 h with intermittent shaking to 
ensure complete solubility of the drug. Then the volume 
was made up to 100 ml with buffer, filtered and analyzed 
for MCZ content at 232 nm.  In vitro disintegration time of 
FDT’s was estimated using the Gohel procedure. Briefly, 
10 ml of water at room temperature was taken in a 
petridish of 10 cm in diameter. The tablet was then 
carefully placed in the centre of petridish and the time 
required for the tablet to completely disintegrate into fine 
particles was noted (Gohel et al., 2004).  
 
In vitro Dissolution Study 
The MCZ release from the prepared FDTs was carried 
out using USP XXIV Type II dissolution apparatus (Electro 
lab, TDT-08L) at a rotation speed of 50 rpm, and a 
temperature of 37.0±0.5 °C. The drug release studies 
were carried out in 7.4 pH phosphate buffer. An aliquot of 
5 ml was collected at predetermined time intervals and 
replaced with fresh dissolution medium.  The samples 
were filtered, by passing through 0.45 µm membrane 
filters (Millipore, USA) & analyzed spectrophotometrically 
at 232 nm. Then a graph was plotted using cumulative 
percent drug release as a function of time and percent 
drug release in 15 min (Q15) was calculated. Initial 
dissolution rate (IDR) was calculated as percentage 
dissolved of drug over the first 15 min per min. Dissolution 
efficiency (DE) was calculated from the area under the 
dissolution curve at time t (measured using the 
trapezoidal rule) and expressed as a percentage of the 
area of the rectangle described by 100% dissolution in the 
same time. Relative dissolution rate (RDR) is the ratio 
between amount of drug dissolved from best formulation 




The stability studies of prepared tablets were planned 
on the F4 tablets according to ICH guidelines. The packed 
samples (n=3) were stored in the stability chamber 
maintained at 40±2 
0
C and 75±5% RH for six months. 
After six months of storage, the samples were collected 
and analyzed for assay and in vitro dissolution rate. Then 
the data was analyzed using paired t-test to test the 
significant variation at 0.05 level of significance (LS). Then 
the similarity index (F2) was calculated between 
dissolution rates of tablets before and after storage to 
prove the stability of tablets (Vemula and Veerareddy, 
2013; Vemula and Bontha, 2013). 
 
RESULTS AND DISCUSSION 
Solubility Studies of MCZ Solid Dispersions  
The aqueous solubility of the solid dispersion 
formulations of different carriers was determined in 
different media i.e., 0.1 N HCl, distilled water and 
phosphate buffer pH 7.4. From the solubility studies of the 
prepared solid dispersions in different media, it was found 
that as the increase in pH of the media increased the 
solubility i.e. MCZ showed superior solubility in 7.4 pH 
phosphate buffer when compared others. The solubility 
data of different formulations using different carriers 
showed in Table 3. From the results given in above 
tables, solid dispersions with PEG 8000 showed 
significant improvement in solubility with increasing PEG 
ratio up to 1:4 ratios, but after no significant improvement 
in solubility by increasing the ratio of carrier. From all the 
solid dispersions, formulation F4 showed highest solubility 
in 7.4 pH phosphate buffer. Similar type of results 
observed in Patel et al., 2011 study i.e., the solubility of 
flurbiprofen was measured in four different media and the 
results showed that the solubility of the flurbiprofen was 
highest at pH 7.2, and decreased as the pH decreases. 
  
Table 3: Solubility studies of MCZ-PEG 8000 solid 




MCZ solubility in mg/ml 





Pure FLB 0.342±0.21 0.961±0.18 0.975±0.23 
F1 0.409±0.19 1.127±0.15 1.424±0.46 
F2 0.487±0.27 1.292±0.28 1.486±0.12 
F3 0.518±0.36 1.343±0.56 1.579±0.28 
F4 0.542±0.13 1.471±0.48 1.663±0.53 
F5 0.604±0.32 1.481±0.75 1.669±0.37 
F6 0.613±0.18 1.489±0.51 1.672±0.72 
 
Drug-carrier Interaction Studies 
The thermograms of the MCZ, PEG 8000, physical 
mixture of MCZ with PEG 8000 were shown in Figure 1. 
The DSC thermograms of MCZ exhibited a sharp 
endothermal peak around 206.66
0
C corresponding to 
melting point. The DSC thermogram of PEG 8000 
exhibited a broad endothermal peak around 69.5
o
C 
corresponding to its melting point. The thermogram of 
physical mixture with PEG 8000 showed a short 
endothermal peak of drug at 206 
0
C indicating that there 
were no interactions between drug and carrier.  
 
Figure 1: DSC thermograms of 1) MCZ 2) PEG 8000 3) 
F4 physical mixture. 
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Evaluation of Flow Properties  
The powder mixture for tablets were characterized with 
respect to angle of repose, bulk density, tapped density 
and Carr’s index (Table 4). Angle of repose was less than 
35° and Carr’s index values were less than 21 for the 
powder mixture of all the batches indicating good to fair 
flowability (Staniforth and Aulton, 2007).  
 
Evaluation of Physical Parameters 
Based on the solubility studies, the better solid 
dispersions were converted into tablets. Table 5 showed 
all the physical parameters determined for MCZ tablets. In 
weight variation test, the pharmacopoeial limits for the 
tablets of not more than 5% of the average weight. The 
tablet hardness and friability were found to be around 3.0 
kg/cm
2
 and 0.38%, demonstrating the integrity and 
strength of tablets. The tablets assay was found to contain 
98.76±1.43%. From the disintegration test, the prepared 
tablets were disintegrated rapidly and it was found to be 
around 120 sec.   
 
In vitro Dissolution Study  
From the in vitro dissolution studies, tablets made from 
1:4 ratio solid dispersion (F4) showed fast dissolution 
(98.52±1.34% in 15 min) than other formulations and 
improved significantly when compared to control tablet 
(Figure 2). From the in vitro dissolution studies, F4 FDTs 
showed significant increase in dissolution rate when 
compared to control tablets with pure drug. In the 
following reported study by Singh et al., similar type of 
solubility enhancement was observed with PEG 6000 
solid dispersions (Singh et al., 2011).  
 
The percent drug release in 15 min (Q15) and initial 
dissolution rate for formulation F4 was 98.52±1.34%, 
6.56%/min. These were very much higher compared to 
control tablets (32.49±1.29 %, 2.17%/min). The relative 
dissolution rate was found to be 3.03 and dissolution 
efficiency was found to be 54.45 and it is increased by 3.5 
fold with F4 formulation compared to control tablets 
(16.55). Overall increase in the dissolution performance of 
the optimized formulation was described in terms of 
dissolution parameters (IDR, DE, RDR) and when 
compared with control tablets and all the above 
parameters were increased in case of F4 formulation 
(Table 6). Similar type of improvement in IDR, DE, RDR 
was reported in the study of Vemula et al. (2011).  
 
 
Figure 2: Dissolution studies of MCZ fast dissolving and 
control tablets  
 
Stability Studies 
After storage of six months, the formulation F4 was 
subjected to a drug assay and in vitro dissolution studies 
(Table 7) and from the statistical analysis there was no 
significant difference between before and after storage 
(P<0.05). The similarity index value between dissolution 
profiles of optimized formulation before and after storage 
was found to be 85.12, which is more than 50 indicates 
similarity between the dissolution profile before and after 
storage (Vemula and Veerareddy, 2013; Vemula and 
Bontha, 2013).   
 
Table 4: Evaluation of pre-compression parameters (Mean ± SD, n=3). 
 
Formulation 














F4 29.15±1.72 0.345 0.407 15.23 
Control 27.36±1.26 0.339 0.397 14.61 
 















F4 201.18±1.72 3.0±0.23 0.38 121±4 98.76±1.43 
Control 201.76±1.39 3.0±0.18 0.33 118±4 99.12±1.38 
* All values represent mean ± standard deviation, n=20; † n=6; ‡ n=3 
 
Table 6: Dissolution parameters of MCZ F4 and control tablets (Mean ± SD, n=3). 
 
Formulation (Q15) IDR (%/min) DE RDR 
F4 98.52±1.34 6.56 54.45 
3.03 
Control 32.49±1.29 2.17 16.55 
 






After 6 months 
storage 
t-test  
at 0.05 LS 
Similarity  
Factor (F2) 
0 0.00±0.00 0.00±0.00 
Not Significant 85.12 
5 42.61±1.37 40.23±1.45 
10 71.34±1.45 69.75±1.24 
15 98.52±1.34 96.79±1.19 
% Assay 98.76±1.43 97.14±1.28 Not Significant -- 
 




Attempts was made to prepare the solid dispersions 
using various weight ratios of meclizine hydrochloride and 
PEG 8000 and evaluated for physiochemical properties. 
In vitro dissolution rate of solid dispersion tablets was 
improved significantly when compared to control tablets 
due to intermolecular interactions between the polymer 
and drug. From the results of in vitro dissolution study, 
tablets containing polyethylene glycol 8000 showed 
almost complete drug release within the 15 min. The 
percent drug release in 15 min (Q15) and initial dissolution 
rate for formulation F4 was 98.52±1.34%, 6.56%/min. 
These were very much higher compared to control tablets 
(32.49±1.29%, 2.17% /min). The relative dissolution rate 
was found to be 3.03 and dissolution efficiency was found 
to be 54.45 and it is increased by 3.5 fold with F4 tablets 
compared to control tablets (16.55). Thus the 
development of the PEG solid dispersions can be a 
promising alternative method to gain the fast dissolution 
rate.  
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